Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

Stat News

STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study

STAT+: Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
ShareXFacebook

Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.

S

Source

Stat News

Read full article at Stat News

Opens original article in a new tab

Advertisement

Related Health Stories

The Hidden Curriculum of Punishment
MedPage Today

The Hidden Curriculum of Punishment

(MedPage Today) -- Two recent tragedies in medical education could not be more different on their surface. In one case, a fourth-year medical student at a school in Minnesota posted crude, demeaning comments about female patients on social media...

Read more →
Advertisement